---
title: "Truist Financial Remains a Buy on Boston Scientific (BSX)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287026605.md"
description: "Truist Financial analyst Richard Newitter has reiterated a Buy rating on Boston Scientific (BSX), with shares closing at $56.81. The analyst consensus is a Strong Buy, with a price target of $87.63, indicating a potential upside of 54.25%. Barclays also maintains a Buy rating with a $96.00 target."
datetime: "2026-05-20T07:45:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287026605.md)
  - [en](https://longbridge.com/en/news/287026605.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287026605.md)
---

# Truist Financial Remains a Buy on Boston Scientific (BSX)

In a report released yesterday, Richard Newitter from Truist Financial reiterated a Buy rating on Boston Scientific. The company’s shares closed yesterday at $56.81.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Newitter covers the Healthcare sector, focusing on stocks such as Boston Scientific, Lantheus, and Insulet. According to TipRanks, Newitter has an average return of 5.8% and a 45.03% success rate on recommended stocks.

Boston Scientific has an analyst consensus of Strong Buy, with a price target consensus of $87.63, implying a 54.25% upside from current levels. In a report released yesterday, Barclays also maintained a Buy rating on the stock with a $96.00 price target.

### Related Stocks

- [BSX.US](https://longbridge.com/en/quote/BSX.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [TFC.US](https://longbridge.com/en/quote/TFC.US.md)
- [LNTH.US](https://longbridge.com/en/quote/LNTH.US.md)
- [PODD.US](https://longbridge.com/en/quote/PODD.US.md)

## Related News & Research

- [Boston Scientific enters into $2 billion accelerated share repurchase agreement | BSX Stock News](https://longbridge.com/en/news/286758956.md)
- [Boston Scientific Targets Growing Aortic Stenosis Market With $1.5 Billion Deal](https://longbridge.com/en/news/286808399.md)
- [BUZZ-Boston Scientific shares rise on $2 bln accelerated buyback](https://longbridge.com/en/news/286801797.md)
- [Boston Scientific Advances Coronary Calcium Treatment With Positive Trial Results](https://longbridge.com/en/news/286942821.md)
- [Securian Asset Management Inc. Sells 31,250 Shares of Boston Scientific Corporation $BSX](https://longbridge.com/en/news/285922673.md)